Bio-Rad Laboratories, Inc. (NYSE:BIO.B – Get Rating)'s share price hit a new 52-week high during trading on Wednesday . The company traded as high as $464.10 and last traded at $464.10, with a volume of 0 shares. The stock had previously closed at $464.10.
Analysts Set New Price Targets
Separately, TheStreet upgraded Bio-Rad Laboratories from a "d+" rating to a "c-" rating in a report on Monday.
Get Bio-Rad Laboratories alerts:Bio-Rad Laboratories Price Performance
The company has a quick ratio of 4.29, a current ratio of 5.55 and a debt-to-equity ratio of 0.12. The stock has a fifty day moving average price of $415.36 and a 200 day moving average price of $411.90.
Bio-Rad Laboratories (NYSE:BIO.B – Get Rating) last announced its earnings results on Thursday, February 16th. The company reported $3.31 EPS for the quarter. The firm had revenue of $730.29 million during the quarter. Bio-Rad Laboratories had a positive return on equity of 4.59% and a negative net margin of 129.66%.
Bio-Rad Laboratories Company Profile
(Get Rating)
Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.
Read More
- Get a free copy of the StockNews.com research report on Bio-Rad Laboratories (BIO.B)
- Put High-Yield Paychex, Inc. On Your Watchlist
- The Squeeze Is On For EVGo, Rally To Follow
- Is The Bottom In For RH, Or Is This Just A Stopping Point?
- Dividend King H.B. Fuller Signals Slowing In 2023
- Is SoFi Technologies a Buy in the Midst of a Banking Crisis?
Receive News & Ratings for Bio-Rad Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Rad Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.